Latest news

Genomics plays a vital role in driving Québec's economic future. That is why Génome Québec aims at advancing knowledge in genomics by funding major research projects. In this section, you will discover all the latest achievements in the field of genomics.

Excellent results for Québec: Genomics Innovation Network

Mar. 31, 2015

Génome Québec salutes the Québec researchers for their performance in the Canadian Genomics Innovation Network competition by winning four of the ten projects!

Congratulations to Philip Awadalla from Sainte-Justine UHC - Université de Montréal, Guillaume Bourque from McGill University, Mark Lathrop from McGill University and Génome Québec Innovation Centre and Pierre Thibault from the Institute for research in immunology and cancer of Université de Montréal

More details...

A new PacBio CSP certification for McGill University and Génome Québec Innovation Centre

Mar. 23, 2015

McGill University and Génome Québec Innovation Centre in the top 6 of PacBio' certified services provider!


This certification provides a competitive advantage to service providers and helps ensure that their customers will receive the highest-quality genetic analysis services.

More details...

Canadians lead in transforming genomic data into knowledge to drive medical innovations

Mar. 18, 2015

Sophisticated software cuts through the complexity of genomic data and makes it accessible to researchers and practitioners

Compute Canada and CANARIE, two critical components of Canada’s national digital infrastructure supporting research, education and innovation, today announced the launch of GenAP, a tool that enables Canadian researchers to easily access and use genomic data to advance our knowledge of human health and disease.

More details...

Large IHEC Data Release: Over 5500 datasets now accessible via the IHEC Data Portal

Mar. 18, 2015

The IHEC Data Portal was developed to integrate and distribute datasets produced by various IHEC (International Human Epigenome Consortium) member consortia. The Portal was created by the team of Dr. Guillaume Bourque at McGill University, through a project funded under the CIHR Canadian Epigenetics, Environment, and Health Research Consortium (CEEHRC). The Portal implements a database and a graphical interface that currently hosts 5667 epigenomic datasets. It provides an overview of all the whole genome experiments produced by IHEC members, categorized by providers, tissue types and assay types. It implements a dynamic grid that can be used to navigate through the datasets and provides links to either visualize the data in a genome browser or download it. A new feature expected for the Data Portal in the near future is a tool for correlation analysis, to provide insights on the similarity of different assays and tissues. By facilitating data distribution and interpretation, the IHEC Data Portal helps accelerate the translation of epigenomics knowledge into health and disease applications. The Portal has also received support from CANARIE, Génome Québec, Génome Canada and Compute Canada.

More details...

Discovery of the Year: the public votes for the team of Dr. Sauvageau!

Mar. 17, 2015

Congratulations to Dr. Sauvageau's team who was voted Québec Science Discovery of the year thanks to the discovery of a new molecule that expands stem cells from umbilical cord blood.


This discovery will significantly increase the availability of compatible cord blood for treating patients with illnesses like leukemia, lymphoma and myeloma. For many patients this therapy constitutes a treatment of last resort.

More details...

Disovery of genetic variations to better understand breast cancer

Mar. 10, 2015

A study carried out by dozens of scientists, and published in Nature Genetics, identified 15 new genetic markers that can increase the risk of breast cancer. Each of these genetic variations, identified through this study and other research, is known to raise a woman's risk of breast cancer by a small amount. It's another step towards a better understanding of how genetic variations work to increase the risk of this type of cancer.

More details...